SE8001689L - 6-beta-substituerade penicillansyror med beta-laktamas-inhibitorverkan - Google Patents

6-beta-substituerade penicillansyror med beta-laktamas-inhibitorverkan

Info

Publication number
SE8001689L
SE8001689L SE8001689A SE8001689A SE8001689L SE 8001689 L SE8001689 L SE 8001689L SE 8001689 A SE8001689 A SE 8001689A SE 8001689 A SE8001689 A SE 8001689A SE 8001689 L SE8001689 L SE 8001689L
Authority
SE
Sweden
Prior art keywords
beta
substituted
acids
lactamas
penicillan
Prior art date
Application number
SE8001689A
Other languages
English (en)
Other versions
SE451329B (sv
Inventor
M S Kellogg
E S Hamanaka
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE8001689L publication Critical patent/SE8001689L/sv
Publication of SE451329B publication Critical patent/SE451329B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8001689A 1979-03-05 1980-03-04 6-beta-jod-substituerade penicillansyror SE451329B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1780979A 1979-03-05 1979-03-05
US06/096,832 US4397783A (en) 1979-03-05 1979-11-23 Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-β-congeners

Publications (2)

Publication Number Publication Date
SE8001689L true SE8001689L (sv) 1980-09-06
SE451329B SE451329B (sv) 1987-09-28

Family

ID=26690341

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8001689A SE451329B (sv) 1979-03-05 1980-03-04 6-beta-jod-substituerade penicillansyror

Country Status (29)

Country Link
US (1) US4397783A (sv)
KR (1) KR840000589B1 (sv)
AR (1) AR225758A1 (sv)
AT (1) AT369744B (sv)
AU (1) AU518472B2 (sv)
CA (1) CA1154011A (sv)
CH (1) CH648850A5 (sv)
DD (1) DD149366A5 (sv)
DE (1) DE3008316C2 (sv)
DK (1) DK157136C (sv)
ES (1) ES8103095A1 (sv)
FI (1) FI71739C (sv)
FR (1) FR2450837A1 (sv)
GB (1) GB2047684B (sv)
GR (1) GR67697B (sv)
HK (1) HK66687A (sv)
IE (1) IE51931B1 (sv)
IL (1) IL59514A (sv)
IT (1) IT1130301B (sv)
KE (1) KE3456A (sv)
LU (1) LU82219A1 (sv)
MY (1) MY8500320A (sv)
NL (1) NL8001286A (sv)
NO (1) NO800617L (sv)
OA (1) OA06496A (sv)
PH (2) PH18550A (sv)
PT (1) PT70898A (sv)
SE (1) SE451329B (sv)
SG (1) SG56484G (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518530A (en) * 1979-03-05 1985-05-21 Pfizer Inc. 6-β-Substituted penicillanic acids as β-lactamase inhibitors
IL59948A0 (en) * 1979-05-21 1980-06-30 Rech Applications Therap Penicillanic acid derivatives,their production and pharmaceutical compositions containing them
US4511512A (en) * 1980-05-01 1985-04-16 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Produktionsaktiensel skab) Substantially pure dicyclohexyl ammonium 6-β-bromo-penicillanate
IE51846B1 (en) * 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
EP0139047A1 (en) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Process for the preparation of 6,6-dibromopenicillanic acid 1,1-dioxide
GB8522156D0 (en) * 1985-09-06 1985-10-09 Leo Pharm Prod Ltd Producing chemical compounds
WO1987006230A1 (en) * 1986-04-10 1987-10-22 Leo Pharmaceutical Products Ltd. A/S Method for preparing penicillanic acid derivatives
PA8579701A1 (es) * 2002-08-23 2005-05-24 Pfizer Prod Inc Profarmaco inhibidor de beta-lactamasa
JP2006526612A (ja) * 2003-06-05 2006-11-24 ファイザー・プロダクツ・インク ベータ−ラクタマーゼ阻害剤・プロドラッグ

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5749555B2 (sv) * 1973-04-04 1982-10-22
US4093625A (en) * 1976-08-09 1978-06-06 Massachusetts Institute Of Technology 6-Sulfur analogs of penicillins and cephalosporins
US4180506A (en) * 1978-01-18 1979-12-25 Rex Pratt 6β-Bromo penicillanic acid
US4203992A (en) * 1978-12-11 1980-05-20 E. R. Squibb & Sons, Inc. β-Bromopenicillanic acid sulfone
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
IL59081A0 (en) * 1979-01-10 1980-05-30 Schering Corp 2-penem compounds and a method for preparing them
EP0013617B1 (en) * 1979-01-10 1984-07-04 Beecham Group Plc Penicillin derivatives, process for their preparation and pharmaceutical compositions containing certain of these compounds

Also Published As

Publication number Publication date
CA1154011A (en) 1983-09-20
DE3008316A1 (de) 1980-09-25
DD149366A5 (de) 1981-07-08
IL59514A (en) 1984-01-31
FI800662A (fi) 1980-09-06
SG56484G (en) 1985-03-08
FI71739C (sv) 1987-02-09
OA06496A (fr) 1981-07-31
US4397783A (en) 1983-08-09
KE3456A (en) 1984-10-12
HK66687A (en) 1987-09-25
GB2047684B (en) 1983-09-28
ATA118980A (de) 1982-06-15
NO800617L (no) 1980-09-08
DK157136C (da) 1990-04-16
LU82219A1 (fr) 1980-09-24
KR840000589B1 (ko) 1984-04-24
IT8020368A0 (it) 1980-03-05
AU518472B2 (en) 1981-10-01
IE51931B1 (en) 1987-04-29
DK157136B (da) 1989-11-13
AR225758A1 (es) 1982-04-30
GB2047684A (en) 1980-12-03
DE3008316C2 (de) 1982-12-16
SE451329B (sv) 1987-09-28
FR2450837A1 (fr) 1980-10-03
GR67697B (sv) 1981-09-07
KR830001941A (ko) 1983-05-19
IL59514A0 (en) 1980-06-30
FR2450837B1 (sv) 1984-01-13
IE800428L (en) 1980-09-05
NL8001286A (nl) 1980-09-09
ES489186A0 (es) 1981-02-16
MY8500320A (en) 1985-12-31
AT369744B (de) 1983-01-25
CH648850A5 (de) 1985-04-15
PT70898A (en) 1980-04-01
PH17879A (en) 1985-01-14
ES8103095A1 (es) 1981-02-16
DK92880A (da) 1980-09-06
IT1130301B (it) 1986-06-11
AU5610580A (en) 1980-09-18
PH18550A (en) 1985-08-09
FI71739B (fi) 1986-10-31

Similar Documents

Publication Publication Date Title
ES8204437A1 (es) Un procedimiento para la preparacion de acidos 6-b-hidroxialquilpenicilanicos y sus derivados.
SE8305916D0 (sv) Mellanprodukter for framstellning av penicillansyra-1,1-dioxider
IE43840L (en) Clavulanic acid derivatives
SE8001689L (sv) 6-beta-substituerade penicillansyror med beta-laktamas-inhibitorverkan
IL72004A (en) Process for debromination of bromopenicillanic acids and derivatives
DE3265082D1 (en) Beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl-(5r) penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor
IE820342L (en) Penicillins
ATE82291T1 (de) Clavamderivate, herstellung und zwischenprodukte.
DE3269029D1 (en) Bis-hydroxymethyl carbonate bridged antibacterial agents
FI102274B1 (sv) Förfarande för framställning av optiskt aktivt cyklobutanon, vilken är en mellanprodukt vid framställningen av optiskt aktiv cyklobutannukleosid, samt mellanprodukt användbar vid förfarandet
ES476259A1 (es) Un procedimiento para la preparacion de un compuesto.
FI864182A (fi) Framstaellningsfoerfarande foer 2-(1-oxo-3-tiolanyl)-2-penem-antibiotika.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8001689-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8001689-2

Format of ref document f/p: F